{"product_id":"diagnostic-pathology-transplant-pathology-hardback-9780323553575","title":"Diagnostic Pathology: Transplant Pathology (Hardback) 9780323553575","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDiagnostic Pathology: Transplant Pathology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eStay up to date with recent changes in all aspects of transplant pathology\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eAnthony C. Chang (Author), Matthew R Lindberg (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323553575, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 16 August 2018\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e600 pages, 1360 illustrations (1360 in full color)\u003cbr\u003e27.6 x 21.5 x 3.3 cm, 1.9 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"This is an excellent resource for transplant pathology. Pathologists and pathology residents who have an interest in transplant associated specimens will find this to be an excellent comprehensive resource.\"\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e-Kyle Perry, MD (Henry Ford Health Systems) \u003cb\u003eDoody's Score: 100-5 Stars!\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003ePart of the highly regarded \u003ci\u003eDiagnostic Pathology \u003c\/i\u003eseries, this updated volume by Drs. Anthony Chang and Robert B. Colvin is an \u003cb\u003eideal point-of-care reference to guide you through the complex realm of transplant pathology\u003c\/b\u003e. Concise, focused chapters, supported by tables, diagrams, radiographs, and photographs, provide \u003cb\u003eessential information to keep you up to date \u003c\/b\u003ewith the impact of new viral infections, updates from the Banff Allograft Conference, new information on next-generation sequencing, and much more.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eMore than 20 experts present their collective knowledge to assist you with different aspects of transplant pathology, including rare issues such as the impact of new viral infections (e.g., the Zika virus on transplant patients who are immunosuppressed)\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePacked with high-quality images that provide examples and potential pitfalls of diagnostic lesions that you are likely to encounter\u003c\/li\u003e \u003cli\u003eTime-saving reference features include bulleted text, tables of diagnostic criteria, annotated images, and an extensive index\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e \u003cli\u003eThoroughly updated content keeps you current with all aspects of transplant immunology and pathology, guiding you expertly through diagnostic challenges such as donor disease, surgical complications, allograft rejection, drug toxicity, opportunistic infections, and\/or recurrent or de novo diseases that can occur simultaneously or at different times\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eNew Banff classifications are integrated into all chapters, covering pathology of all clinical organ transplants, including kidney, heart, lung, liver, pancreas, small bowel, and vascularized composite allografts as well as bone marrow allografts\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eNew coverage includes next-generation sequencing, which is quickly becoming the standard for HLA testing, as well as new drugs that are in clinical trials for the treatment of antibody-mediated rejection\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eExpert Consult™ eBook version included with purchase. This \u003cb\u003eenhanced eBook experience\u003c\/b\u003e allows you to search all of the text, figures, and references from the book on a variety of devices\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eImmunology \u003c\/p\u003e \u003cp\u003eImmune Response in Organ Transplantation\u003c\/p\u003e \u003cp\u003eRegulatory Immune Cells and Transplant Tolerance \u003c\/p\u003e \u003cp\u003eNK Cells \u003c\/p\u003e \u003cp\u003eComplement \u003c\/p\u003e \u003cp\u003eLaboratory-Based Immune Monitoring in Organ Transplantation\u003c\/p\u003e \u003cp\u003eHLA Testing \u003c\/p\u003e \u003cp\u003eHuman Leukocyte Antigen System\u003c\/p\u003e \u003cp\u003eHistocompatibility Testing\u003c\/p\u003e \u003cp\u003eTransplantation and HLA\u003c\/p\u003e \u003cp\u003eABO Blood Group Antigens and Transplantation\u003c\/p\u003e \u003cp\u003eApheresis and Transplantation\u003c\/p\u003e \u003cp\u003eHLA and Transfusion\u003c\/p\u003e \u003cp\u003eImmunosuppressive Drugs\u003c\/p\u003e \u003cp\u003eMechanism of Action of Immunosuppressive Drugs\u003c\/p\u003e \u003cp\u003eTherapeutic Drug Monitoring in Transplant Patients\u003c\/p\u003e \u003cp\u003eHistory of Immunosuppression Drugs in Transplantation\u003c\/p\u003e \u003cp\u003eKidney Transplantation\u003c\/p\u003e \u003cp\u003eHistory of Kidney Transplantation\u003c\/p\u003e \u003cp\u003ePathologic Classification of Renal Allograft Diseases\u003c\/p\u003e \u003cp\u003eEvaluation of the End-Stage Kidney\u003c\/p\u003e \u003cp\u003eEvaluation of Allograft Kidney\u003c\/p\u003e \u003cp\u003eEvaluation of the Donor Kidney\u003c\/p\u003e \u003cp\u003eEvaluation of Transplant Nephrectomy\u003c\/p\u003e \u003cp\u003eEvaluation of Fibrosis\u003c\/p\u003e \u003cp\u003eProtocol Biopsies\u003c\/p\u003e \u003cp\u003eAccommodation \u003c\/p\u003e \u003cp\u003eTolerance \u003c\/p\u003e \u003cp\u003eSurgical Complications\u003c\/p\u003e \u003cp\u003eAcute Allograft Ischemia\u003c\/p\u003e \u003cp\u003eUrine Leak \u003c\/p\u003e \u003cp\u003eLymphocele \u003c\/p\u003e \u003cp\u003eRenal Artery or Vein Thrombosis\u003c\/p\u003e \u003cp\u003eTransplant Renal Artery Stenosis\u003c\/p\u003e \u003cp\u003eAllograft Rejection\u003c\/p\u003e \u003cp\u003eHyperacute Rejection\u003c\/p\u003e \u003cp\u003eAcute T-Cell-Mediated Rejection\u003c\/p\u003e \u003cp\u003eChronic T-Cell-Mediated Rejection\u003c\/p\u003e \u003cp\u003eAcute Antibody-Mediated Rejection\u003c\/p\u003e \u003cp\u003eChronic Antibody-Mediated Rejection\u003c\/p\u003e \u003cp\u003eRecurrent Diseases\u003c\/p\u003e \u003cp\u003eDiseases That Recur in Allografts\u003c\/p\u003e \u003cp\u003eDe Novo Diseases\u003c\/p\u003e \u003cp\u003eDe Novo Focal Segmental Glomerulosclerosis\u003c\/p\u003e \u003cp\u003eDe Novo Membranous Glomerulonephritis\u003c\/p\u003e \u003cp\u003eAnti-GBM Disease in Alport Syndrome\u003c\/p\u003e \u003cp\u003eHyperperfusion Injury\u003c\/p\u003e \u003cp\u003eEngraftment Syndrome\u003c\/p\u003e \u003cp\u003eKidney Diseases in Nonrenal Transplant Recipients\u003c\/p\u003e \u003cp\u003eGraft-vs.-Host Glomerulopathies\u003c\/p\u003e \u003cp\u003eDrug Toxicities \u003c\/p\u003e \u003cp\u003eCalcineurin Inhibitor Toxicity\u003c\/p\u003e \u003cp\u003emTOR Inhibitor Toxicity\u003c\/p\u003e \u003cp\u003eInfections \u003c\/p\u003e \u003cp\u003eAcute Pyelonephritis\u003c\/p\u003e \u003cp\u003ePolyomavirus Nephritis\u003c\/p\u003e \u003cp\u003eAdenovirus, Kidney\u003c\/p\u003e \u003cp\u003eCytomegalovirus Infection\u003c\/p\u003e \u003cp\u003eHistoplasmosis\u003c\/p\u003e \u003cp\u003eCandidiasis \u003c\/p\u003e \u003cp\u003eCryptococcosis\u003c\/p\u003e \u003cp\u003eMucormycosis\u003c\/p\u003e \u003cp\u003eAspergillosis \u003c\/p\u003e \u003cp\u003eCoccidioidomycosis\u003c\/p\u003e \u003cp\u003eParacoccidioidomycosis\u003c\/p\u003e \u003cp\u003eMicrosporidiosis\u003c\/p\u003e \u003cp\u003eTuberculosis \u003c\/p\u003e \u003cp\u003eMalakoplakia \u003c\/p\u003e \u003cp\u003eNocardiosis \u003c\/p\u003e \u003cp\u003eLiver Transplantation\u003c\/p\u003e \u003cp\u003ePathologic Classification of Liver Allograft Diseases\u003c\/p\u003e \u003cp\u003eGross Evaluation of Failed Native Liver\u003c\/p\u003e \u003cp\u003eEvaluation of Failed Liver Allograft\u003c\/p\u003e \u003cp\u003eEvaluation of the Donor Liver\u003c\/p\u003e \u003cp\u003eHistory of Liver Transplantation\u003c\/p\u003e \u003cp\u003ePosttransplant Surgical Complications\u003c\/p\u003e \u003cp\u003ePreservation Injury\u003c\/p\u003e \u003cp\u003eHepatic Artery Thrombosis\u003c\/p\u003e \u003cp\u003ePortal Vein Thrombosis\u003c\/p\u003e \u003cp\u003eBile Duct Stricture, Leak, Sludge, Biloma\u003c\/p\u003e \u003cp\u003eHepatic Venous Outflow Obstruction\u003c\/p\u003e \u003cp\u003eHyperperfusion Syndrome\u003c\/p\u003e \u003cp\u003eAllograft Rejection\u003c\/p\u003e \u003cp\u003eAcute Cellular Rejection, Liver\u003c\/p\u003e \u003cp\u003eAntibody-Mediated Rejection, Liver\u003c\/p\u003e \u003cp\u003eChronic (Ductopenic) Rejection\u003c\/p\u003e \u003cp\u003eRecurrent Diseases In Liver Allograft\u003c\/p\u003e \u003cp\u003eRecurrent Hepatitis B Virus\u003c\/p\u003e \u003cp\u003eRecurrent Hepatitis C Virus\u003c\/p\u003e \u003cp\u003eFibrosing Cholestatic HBV or HCV Hepatitis\u003c\/p\u003e \u003cp\u003eRecurrent Autoimmune Hepatitis\u003c\/p\u003e \u003cp\u003eRecurrent Primary Biliary Cholangitis\u003c\/p\u003e \u003cp\u003eRecurrent Primary Sclerosing Cholangitis\u003c\/p\u003e \u003cp\u003eRecurrent Fatty Liver Disease\u003c\/p\u003e \u003cp\u003eInfections \u003c\/p\u003e \u003cp\u003eCytomegalovirus\u003c\/p\u003e \u003cp\u003eHerpes Simplex Virus\u003c\/p\u003e \u003cp\u003eAdenovirus, Liver\u003c\/p\u003e \u003cp\u003eHepatitis E Virus\u003c\/p\u003e \u003cp\u003eEpstein-Barr Virus, Liver\u003c\/p\u003e \u003cp\u003eFungal Infections, Liver\u003c\/p\u003e \u003cp\u003eLate-Graft Dysfunction\u003c\/p\u003e \u003cp\u003ePlasma Cell-Rich Rejection\u003c\/p\u003e \u003cp\u003eGraft-vs.-Host Disease, Liver\u003c\/p\u003e \u003cp\u003eHeart Transplantation\u003c\/p\u003e \u003cp\u003ePathologic Classification of Cardiac Allograft Diseases\u003c\/p\u003e \u003cp\u003eEvaluation of Failed Native and Transplanted Heart\u003c\/p\u003e \u003cp\u003eHistory of Heart Transplantation\u003c\/p\u003e \u003cp\u003eEvaluation of Explanted Heart\u003c\/p\u003e \u003cp\u003eIschemic Heart Disease\u003c\/p\u003e \u003cp\u003eDilated Cardiomyopathy\u003c\/p\u003e \u003cp\u003eHypertrophic Cardiomyopathy\u003c\/p\u003e \u003cp\u003eCongenital Heart Disease\u003c\/p\u003e \u003cp\u003eSarcoidosis, Heart\u003c\/p\u003e \u003cp\u003eArrhythmogenic Right Ventricular Cardiomyopathy\u003c\/p\u003e \u003cp\u003eOther Causes of End-Stage Heart Disease\u003c\/p\u003e \u003cp\u003eAllograft Rejection\u003c\/p\u003e \u003cp\u003eAcute Cellular Rejection, Heart\u003c\/p\u003e \u003cp\u003eAntibody-Mediated Rejection, Heart\u003c\/p\u003e \u003cp\u003eChronic Allograft Vasculopathy, Heart\u003c\/p\u003e \u003cp\u003eNoninfectious Lesions\u003c\/p\u003e \u003cp\u003eQuilty Lesions\u003c\/p\u003e \u003cp\u003eSite of Previous Biopsy\u003c\/p\u003e \u003cp\u003eInfections \u003c\/p\u003e \u003cp\u003eMyocarditis \u003c\/p\u003e \u003cp\u003eLung Transplantation\u003c\/p\u003e \u003cp\u003ePathologic Classification of Lung Allograft Diseases\u003c\/p\u003e \u003cp\u003eExamination of Native and Transplanted Lungs\u003c\/p\u003e \u003cp\u003eHistory of Lung Transplantation\u003c\/p\u003e \u003cp\u003eEvaluation of Failed Native Lung\u003c\/p\u003e \u003cp\u003eEmphysema \u003c\/p\u003e \u003cp\u003eCystic Fibrosis\u003c\/p\u003e \u003cp\u003eIdiopathic Pulmonary Fibrosis\u003c\/p\u003e \u003cp\u003eConnective Tissue Disease-Associated Lung Disease\u003c\/p\u003e \u003cp\u003eSarcoidosis, Lung\u003c\/p\u003e \u003cp\u003ePulmonary Arterial Hypertension\u003c\/p\u003e \u003cp\u003eOther Causes of End-Stage Lung Disease\u003c\/p\u003e \u003cp\u003eSurgical Complications\u003c\/p\u003e \u003cp\u003eSurgical Aspects and Complications, Lung\u003c\/p\u003e \u003cp\u003eAllograft Rejection\u003c\/p\u003e \u003cp\u003ePathologic Classification of Rejection\u003c\/p\u003e \u003cp\u003eAntibody-Mediated Rejection, Lung\u003c\/p\u003e \u003cp\u003eAcute Cellular Rejection, Grade A\u003c\/p\u003e \u003cp\u003eAcute Cellular Rejection, Grade B\u003c\/p\u003e \u003cp\u003eChronic Allograft Dysfunction, Lung\u003c\/p\u003e \u003cp\u003eNoninfectious Lesions\u003c\/p\u003e \u003cp\u003eOrganizing Pneumonia\u003c\/p\u003e \u003cp\u003eMicroaspiration\u003c\/p\u003e \u003cp\u003eInfections \u003c\/p\u003e \u003cp\u003eBacterial Infections\u003c\/p\u003e \u003cp\u003eViral Infections\u003c\/p\u003e \u003cp\u003eFungal Infections, Lung\u003c\/p\u003e \u003cp\u003eIntestinal Transplantation\u003c\/p\u003e \u003cp\u003ePathologic Classification of Intestinal Allograft Diseases\u003c\/p\u003e \u003cp\u003eIndications and Evaluation of Explant\u003c\/p\u003e \u003cp\u003eReperfusion Injury\u003c\/p\u003e \u003cp\u003eHistory of Intestinal and Multivisceral Transplantation\u003c\/p\u003e \u003cp\u003eAllograft Rejection\/Immunological Injury\u003c\/p\u003e \u003cp\u003eAcute Antibody-Mediated Rejection, Intestine\u003c\/p\u003e \u003cp\u003eAcute Cellular Rejection, Intestine\u003c\/p\u003e \u003cp\u003eChronic Rejection, Intestine\u003c\/p\u003e \u003cp\u003eStomach Rejection\u003c\/p\u003e \u003cp\u003eColon Rejection\u003c\/p\u003e \u003cp\u003eGraft-vs.-Host Disease, Intestine\u003c\/p\u003e \u003cp\u003eInfections \u003c\/p\u003e \u003cp\u003eBacterial and Fungal Infections\u003c\/p\u003e \u003cp\u003eAdenovirus, Intestine\u003c\/p\u003e \u003cp\u003eRotavirus, Cytomegalovirus, and Herpes Simplex Virus\u003c\/p\u003e \u003cp\u003eEpstein-Barr Virus, Intestine\u003c\/p\u003e \u003cp\u003ePancreas Transplantation\u003c\/p\u003e \u003cp\u003ePathologic Classification of Pancreas Allograft Diseases\u003c\/p\u003e \u003cp\u003eClinical Considerations in Pancreas Transplant Evaluation \u003c\/p\u003e \u003cp\u003eHistory of Pancreas Transplantation\u003c\/p\u003e \u003cp\u003eSurgical Complications\u003c\/p\u003e \u003cp\u003eSurgical Aspects and Complications, Pancreas \u003c\/p\u003e \u003cp\u003eAllograft Rejection\u003c\/p\u003e \u003cp\u003eAcute Cellular Rejection, Pancreas\u003c\/p\u003e \u003cp\u003eAntibody-Mediated Rejection, Pancreas\u003c\/p\u003e \u003cp\u003eChronic Allograft Rejection\/Graft Sclerosis\u003c\/p\u003e \u003cp\u003eGraft Dysfunction\u003c\/p\u003e \u003cp\u003eRecurrent Diabetes Mellitus\u003c\/p\u003e \u003cp\u003eIslet Cell Toxicity and Islet Amyloid Deposition\u003c\/p\u003e \u003cp\u003eInfections \u003c\/p\u003e \u003cp\u003eIntraabdominal and Opportunistic Infections \u003c\/p\u003e \u003cp\u003eVascularized Composite Allotransplantation\u003c\/p\u003e \u003cp\u003eHistory of Vascularized Composite Allotransplantation\u003c\/p\u003e \u003cp\u003eAllograft Rejection\u003c\/p\u003e \u003cp\u003eAcute T-Cell- and Antibody-Mediated Rejection\u003c\/p\u003e \u003cp\u003eChronic Rejection\u003c\/p\u003e \u003cp\u003ePosttransplant Neoplastic Disorders\u003c\/p\u003e \u003cp\u003ePosttransplant Lymphoproliferative Disease\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pathology [\u003ca title=\"See our other books on Pathology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pathology%20%5BMMF%5D%22\"\u003eMMF\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648810275096,"sku":"9780323553575","price":153.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323553575_a6df9e09-3de1-44b0-980e-73e4d19023ed.jpg?v=1694989957","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/diagnostic-pathology-transplant-pathology-hardback-9780323553575","provider":"Freshly Printed Books","version":"1.0","type":"link"}